Verve Therapeutics Inc. (VERV)

6.18

-0.15 (-2.37%)

At close: Mar 03, 2025, 3:59 PM

6.15

-0.57%

After-hours: Mar 03, 2025, 04:27 PM EST

Verve Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19
Net Income	-198.71M	-200.07M	-157.39M	-120.31M	-45.7M	-19.3M
Depreciation & Amortization	n/a	5.46M	2.8M	1.53M	1.33M	106K
Stock-Based Compensation	43.26M	35.12M	22.48M	7.07M	850K	446K
Other Working Capital	-3.07M	13.79M	13.6M	-9.74M	4.54M	926K
Other Non-Cash Items	23K	-7.75M	1.39M	35.23M	5.24M	8.71M
Deferred Income Tax	n/a	n/a	n/a	1.51M	380K	-72K
Change in Working Capital	-2.26M	17.7M	8.38M	-2.91M	2.64M	2.66M
Operating Cash Flow	-157.69M	-149.55M	-122.33M	-77.88M	-35.27M	-7.44M
Capital Expenditures	-3.74M	-9.28M	-13.23M	-4.36M	-3.42M	-1.86M
Acquisitions	n/a	n/a	142.72M	234.74M	47.7M	10.9M
Purchase of Investments	n/a	-517.14M	-479.4M	-371.49M	-98.48M	-22M
Sales Maturities Of Investments	n/a	554.11M	336.68M	136.75M	50.78M	11.1M
Other Investing Acitivies	74.88M	n/a	-142.72M	-234.74M	-47.7M	-10.9M
Investing Cash Flow	74.88M	27.69M	-155.96M	-239.1M	-51.13M	-12.76M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.46M	2.12M	2.46M	91.88M	92.63M	17.95M
Financial Cash Flow	49.2M	212.58M	328.96M	377.09M	92.63M	17.95M
Net Cash Flow	-33.62M	90.72M	50.67M	60.11M	6.24M	-2.25M
Free Cash Flow	-161.43M	-158.83M	-135.56M	-82.24M	-38.69M	-9.3M